FDA approves first new antibiotic for UTIs in nearly 30 years
The FDA approved a new antibiotic for UTIs from drugmaker GSK. The drug, Blujepa, is for women and girls ages 12 and up.
The American Journal of Managed Care2d
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
WISN 12 News2d
FDA approves a new kind of oral antibiotic to treat urinary tract infections
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
FDA approves Tremfya for active Crohn's disease in adults
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...
The Lancet15d
Eradication efficacy and the effect of vonoprazan–amoxicillin dual therapy on gut microbiota and antibiotic resistome
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. We congratulate Yi Hu and colleagues on their high-quality article published in The Lancet Microbe, which ...